Venture Capital Report

Size: px
Start display at page:

Download "Venture Capital Report"

Transcription

1 Europe 4Q 2014

2 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 4Q 2014 include: European venture capital fundraising experiences uptick from 3Q 2014, but suffers declines in both fund closings and euros raised for the 12 month period; Venture capital investment into European companies falls from 3Q 2014, but improves by a quarter year over year; Despite an overall fall in exit activity, the total amount raised through venture-backed Initial public offerings (IPOs) reached its highest point since 2Q

3 FUNDRAISING European Venture Capital Fundraising Experiences Uptick in 4Q European venture capital funds accumulated 927 million during 4Q 2014, an increase of 33% in euros raised and 20% in the number of funds with closings from 3Q Despite the uptick in fundraising from 3Q 2014, the number of funds with closings during 4Q 2014 fell by 51% compared with the same period last year, while euros raised fell by 49%. The largest fund of the quarter was Principia SGR s Fund III which raised 160 million, accounting for 17% of the total amount raised for 4Q Overall, the number of fund closings in 2014 was down by 4% to 76 from the year prior, while the total amount raised by venture funds fell by 18% from 2013 to 3.4 billion. European VC Fundraising ( ) Based on multiple closings Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Amount Raised ( B) Number of Funds

4 Largest European VC Funds Raised in 4Q 2014 FUNDRAISING Firm Name Fund Name Amount ( M) Closed in 4Q Location Offering Status Fund Type Fund Category Closing Type Principia SGR Principia Fund III Milan, Italy Open Multi-stage venture capital Venture Capital First Infocomm Investments Pte. Ltd. Infocomm European Technology Fund Singapore, Singapore Closed Early-stage venture capital Venture Capital Final Northzone Ventures AS Northzone VII Oslo, Norway Closed Early-stage venture capital Venture Capital Final Forbion Capital Partners Forbion Capital Fund III Naarden, Netherlands Open Multi-stage venture capital Venture Capital First Advent Venture Partners LLP Advent Life Sciences Fund II LP London, United Kingdom Closed Multi-stage venture capital Venture Capital Final 4

5 Investment into European Venture-backed Companies Falls in 4Q 2014 European companies raised 1.8 billion for 332 deals during 4Q 2014, a fall of 24% in the amount raised from 3Q 2014 despite just five fewer deals being completed. In contrast with the year ago period, investment improved by 1% despite a 28% reduction in the number of completed deals. In 2014 as a whole, European venture-backed companies attracted 7.9 billion across 1460 deals, a decline of 11% in deals completed from 2013 but an improvement of 25% in euros invested. Equity Financings into Europe based, VC-backed Companies ( ) Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Amount Raised ( B) Number of Deals

6 Equity Financings into Europe-based, VC-backed Companies, by Round Class ( ) Number of Deals Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Seed First Second Later Restart

7 Equity Financings into Europe-based, VC-backed Companies, by Round Class (Year over Year, ) Number of Deals Restart Later Second First Seed

8 Equity Financings into Europe-based, VC-backed Companies, by Round Class ( ) Amount Raised ( M) 1,200 1, Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Seed First Second Later , Restart

9 Equity Financings into Europe-based, VC-backed Companies, Median Equity Deal Size ( M) ( ) Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Median Equity Deal Size ( M)

10 Equity Financings into Europe-based, VC-backed Companies, by Industry Group (4Q 2014) Business and Financial received the largest allocation of investment during 4Q 2014 (32%), accumulating 557 million through 80 deals. The sector remained the most attractive sector despite investment dropping by 41% from 3Q Deal flow remained flat. Healthcare rose to second in terms of equity financing, taking a 30% share of all 4Q 2014 investment. The sector raised 535 million across 60 deals, an increase of 64% in capital raised and 25% in deals completed from the previous quarter. Consumer was pushed down to third, with companies in the sector gathering 18% of the total amount invested for the quarter. The sector received 327 million across 96 deals; a fall of 53% and 3% from 3Q 2014 in capital invested and deal flow respectively. 4Q'14 Industry Breakdown By Number of Deals 4Q 14 Industry Breakdown By Amount Raised 21% 24% Business and Financial Consumer Goods 1% 15% 32% Business and Financial Consumer Goods 2% Consumer Consumer 18% 2% Energy & Utilities Healthcare 30% 2% Energy & Utilities Healthcare 4% 29% Industrial Goods & Materials 2% 18% Industrial Goods & Materials (0.5%) Information Technology Information Technology 10

11 Equity Financings into Europe-based, VC-backed Companies, by Industry Group (2014) 2014 Industry Breakdown By Number of Deals 2014 Industry Breakdown By Amount Raised ($B) Business and Financial Consumer Goods Consumer 1% 12% Business and Financial 31% Consumer Goods Consumer Energy & Utilities Healthcare Industrial Goods & Materials 22% 3% 29% 2% Energy & Utilities Healthcare Industrial Goods & Materials Information Technology Information Technology 11

12 Top 5 Deals into European VC-backed Companies (4Q 2014) Co. Name Location Industry Group Industry Segment Industry Code Brief Description Close Date Round Type Raised ( M) Round Investors (* denotes lead) Adyen BV Netherlands Business and Financial Financial Institutions and Payment/ Transactional Processing Provider of an Internet payment system for international merchants. 16/12/2014 Second Felicis Ventures, General Atlantic LLC*, Index Ventures, Temasek Holdings Pvt. Ltd. Verne Global Iceland Information Technology Electronics and Computer Hardware Data Storage Provider of renewable energy-powered data centers. 31/12/2014 Second General Catalyst Partners, Novator Partners, Stefnir*, Wellcome Trust Powa Technologies Ltd. United Kingdom Business and Financial Financial Institutions and Payment/ Transactional Processing Provider of an integrated mobile payments and e-commerce platform. 7/11/2014 Second Wellington Management Co. LLP* Cell Medica Ltd. United Kingdom Healthcare Biopharmaceuticals Biotechnology Therapeutics Provider of antigenspecific T-Cell immunotherapy treatments for the treatment of infectious disease and cancer. 25/11/2014 4th Imperial Innovations*, Invesco Perpetual, Woodford Investment Management LLP Ascendis Pharma A/S Denmark Healthcare Biopharmaceuticals Drug Development Technologies Developer of long-acting prodrug therapies to address large markets with significant unmet medical needs. 24/11/2014 3rd Janus Capital Group, OrbiMed Advisors LLC*, RA Capital Management LLC, Rock Springs Capital Management, Sectoral Asset Management Inc., Sofinnova Partners, Sofinnova Ventures Inc.*, Venrock, Vivo Capital* 12

13 Most Active Investors for Europe-based, VC-backed Companies by Deals Completed (4Q 2014) High-Tech Gruenderfonds Management GmbH Truffle Capital SAS Bpifrance Investment Northzone Ventures AS Kima Ventures 13

14 Equity Financings into Europe-based, VC-backed Companies, by Country (4Q 2014) The United Kingdom was the most favoured destination for equity financing during 4Q 2014, receiving 524 million across 69 deals. The country took in 30% of all investment into European VC-backed companies for the quarter. Germany placed second, capturing 18% of European investment. Investment fell by 73% from the prior quarter to total 322 million. Deal flow remained relatively stable, however, with 66 completed. The Netherlands rose to third position raising 243 million, a 14% share of investment. France placed in fourth position with a 12% share, raising 218 million during 3Q Number of Deals in 4Q 2014 by Country (Top 4) Amount Raised in 4Q 2014 by Country (Top 4) 33% 21% 20% United Kingdom Germany France Spain Rest of Europe 12% 26% 30% United Kingdom Germany Netherlands France Rest of Europe 8% 18% 18% 14% 14

15 LIQUIDITY Europe Sees Overall Decrease in 4Q 2014 Venture Exit Activity 42 venture-backed M&As took place in Europe during 4Q 2014, down 9% from 3Q 2014 but one up on the figure for 4Q The largest M&A for 4Q 2014 was Belgium s Clear2Pay NV, an e-payment solutions provider, which was acquired by Fidelity National Information for 375 million. 55 venture-backed IPOs took place during 2014, tripling the number of listings seen across Europe in M&As were completed during the course of 2014, a 21% increase on the 166 that took place during Exit Opportunities for European VC backed Companies ( ) 4Q'14 3Q'14 2Q'14 1Q'14 4Q'13 3Q'13 2Q'13 1Q'13 4Q'12 3Q'12 2Q'12 1Q'12 4Q' Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 IPOs M&As

16 Top 3 M&As in Europe (4Q 2014) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ( M) Acquirer Clear2Pay NV Mechelen, Belgium Provider of e-payment solutions. Vertical Market Applications Software Software Information Technology 2/10/2014 Acquisition FIdelity National Information SuperDerivatives Inc. London, United Kingdom Provider of cloudbased derivatives data and technology for financial and commodity markets worldwide. Financial Data/Information Financial Institutions and Business and Financial 8/10/2014 Acquisition Intercontinental Exchange Telerik AD Sofia, Bulgaria Provider of an end-toend platform that combines user interface (UI) tools and cloud services. Software Development Tools Software Information Technology 2/12/2014 Acquisition Progress Software Corp. 16

17 LIQUIDITY European VC-backed IPOs ( ) 10 IPOs were completed during 4Q 2014, a decline of 38% from the previous quarter s total but an increase of one on those completed during 4Q IPOs raised 2.3 billion during 4Q 2014, more than six times the figure seen in 4Q 2013 and the highest sum since 2Q 2000 when 71 IPOs raised a total of 3.8 billion. The largest European VC-backed IPO of 4Q 2014 was Rocket Internet AG s October listing on the Frankfurt Stock Exchange. The company raised a total of 1.4 billion, accounting for 62% of the total amount raised through European venture-backed company IPOs for the quarter. European VC-backed IPO Activity ( ) 2, , , , Q'11 1Q'12 2Q'12 3Q'12 4Q'12 1Q'13 2Q'13 3Q'13 4Q'13 1Q'14 2Q'14 3Q'14 4Q'14 Raised ( M) through IPO ,250 Number of IPOs

18 Top 3 IPOs in Europe (4Q 2014) LIQUIDITY Company Name Country Brief Description Industry Code Industry Segment Industry Group Close Date Raised through IPO ( M) Exchange/ Symbol Rocket Internet AG Germany Operator of an e- commerce focused Incubators/Business venture capital (VC) firm Development and a startup incubator. Business Support Business and Financial 2/10/2014 1, XETRA: RKET Zalando SE Germany Provider of an e- commerce platform specializing in the retail of brand name shoes. Clothing/Accessory Retailers Retailers Consumer 1/10/ XETRA: ZAL Forward Pharma A/S Denmark Developer of immunomodulatory drugs for the treatment of immune disorders. Biotechnology Therapeutics Biopharmaceuticals Healthcare 15/10/ NASDAQ: FWP 18

19 ABOUT US Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service providers find deal and partnership opportunities, perform comprehensive due diligence, and examine trends in venture capital investment, fund-raising, and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry, and stage of development throughout the world. The investment figures included in this release are based on aggregate findings of Dow Jones' proprietary research and are contained in VentureSource. This data was collected through surveys of professional firms, interviews with company executives, and from secondary sources. These venture capital statistics cover equity investments into early stage, innovative companies and do not include companies receiving funding solely from corporate, individual, and/or government investors. Figures contained throughout the report current at time of editorial but are subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities or to provide investment advice. About Dow Jones Dow Jones & Company is a global provider of news and business information, delivering content to consumers and organizations via newspapers, Web sites, apps, video, newsletters, magazines, proprietary databases, conferences, and radio. Dow Jones has produced unrivalled quality content for over 120 years and today has one of the world s largest news-gathering operations with nearly 2,000 journalists in more than 80 bureaus, including The Wall Street Journal, America s largest newspaper by paid circulation. Other premier brands include Barron s, MarketWatch, and Dow Jones, its flagship news and analytics platform. Dow Jones publishes in 13 languages and distributes content in 28 languages, combining technology with news and data to support business decision making. The company pioneered the first successful paid online news site and its industry leading innovation enables it to serve customers wherever they may be, via the Web, mobile devices, Internet-connected televisions, and tablets. MEDIA CONTACT: Kate Dobbin 44 (0) Kate.Dobbin@dowjones.com 19

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report China 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

VentureSource U.S. -- 4Q 2013

VentureSource U.S. -- 4Q 2013 U.S. -- 4Q 2013 The following report presents DJX VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

VentureSource China -- 3Q 2014

VentureSource China -- 3Q 2014 China -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, and liquidity. The included charts and graphs offer a comprehensive

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

VentureSource China -- 1Q 2014

VentureSource China -- 1Q 2014 China -- 1Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, and liquidity. The included charts and graphs offer a comprehensive

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 1 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION FOR IMMEDIATE RELEASE For more information: Adam Wade Dow Jones Financial Information Services (415) 439-6666 adam.wade@dowjones.com AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS

More information

Silicon Valley Venture Capital Survey Second Quarter 2018

Silicon Valley Venture Capital Survey Second Quarter 2018 fenwick & west Silicon Valley Venture Capital Survey Second Quarter 2018 Full Analysis Silicon Valley Venture Capital Survey Second Quarter 2018 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark

More information

Venture Capital Industry Overview. Powered By:

Venture Capital Industry Overview. Powered By: Venture Capital Industry Overview Powered By: U.S. U.S. Fundraising Fundraising Slows in 1Q 05 Commitments to Venture Capital Funds $80 $83.5 Funds Raised ($B) $60 $40 $20 $0 $58.8 $50.5 $26.9 $17.1 $17.7

More information

VentureSource U.S. -- 3Q 2014

VentureSource U.S. -- 3Q 2014 U.S. -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 4Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Silicon Valley Venture Capital Survey Third Quarter 2017

Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Silicon Valley Venture Capital Survey Third Quarter 2017 Full Analysis Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Full Analysis Cynthia Clarfield Hess, Mark

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 3Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000 CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN

More information

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010) Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010) Background We analyzed the terms of venture financings for 126 companies headquartered in Silicon Valley that reported raising

More information

2013 venture capital trends summary

2013 venture capital trends summary 213 venture capital trends summary Prepared by: Hitesh Kothari, Director, McGladrey LLP hitesh.kothari@mcgladrey.com August 213 Fundraising by venture capital funds In the first half of 213, 88 venture

More information

Digital Health Funding and M&A

Digital Health Funding and M&A Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom

More information

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Fenwick fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Survey Intro and Background

More information

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year www.pwc.com Medtech Slowdown Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year February 2014 2 PwC US venture capital funding for

More information

The percentage of Series A rounds declined significantly, to 12% of all deals.

The percentage of Series A rounds declined significantly, to 12% of all deals. Silicon Valley Venture Capital Survey Fourth Quarter 2012 Barry Kramer and Michael Patrick Fenwick fenwick & west llp Background We analyzed the terms of venture financings for 116 companies headquartered

More information

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp 2Q13 Trends in Terms of Venture Financings in Silicon Valley Second Quarter 2013 Fenwi wick fenwick & west llp Silicon Valley Venture Capital Survey Second Quarter 2013 Barry Kramer and Michael Patrick

More information

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd. IVC-MEITAR HIGH-TECH EXITS H1/ 215 REPORT IVC-Meitar 214 Exits Report Prepared by IVC Research Center Ltd. Israeli High-Tech Exit Highlights Exit proceeds in H1/215 reached ¾ of total exits for 214 Average

More information

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp 3Q13 Trends in Terms of Venture Financings in Silicon Valley Third Quarter 2013 Fenwick fenwick & west llp Silicon Valley Venture Capital Survey Third Quarter 2013 Barry Kramer and Michael Patrick Fenwick

More information

Israel Venture Capital Investments Report Q3 2017

Israel Venture Capital Investments Report Q3 2017 Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017 Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED.

More information

2013 Global venture capital confidence survey results. How confident are investors?

2013 Global venture capital confidence survey results. How confident are investors? 2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing

More information

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS INDUSTRY RE FUNDS 1969 to present Industry surveys, quarterly and annual fund reports 9,240+ venture capital and private equity funds Venture capital and buyout funds that have invested in companies Name

More information

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Fenwick fenwick & west llp 1h 2012 Trends in Terms of U.S. Life Science Venture Financings First Half 2012 Survey Introduction

More information

Global Clean Energy Review 2Q12 Analytics and Graphs VB/Research Ltd All rights reserved

Global Clean Energy Review 2Q12 Analytics and Graphs VB/Research Ltd All rights reserved Global Clean Energy Review 2Q12 Analytics and Graphs VB/Research Ltd. 2012 All rights reserved Contacts For any questions regarding the information contained herewith or request additional data / information,

More information

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE CONTACTS Laura Cruz Tenor Communications for NVCA 1.917.406.7517 laura@tenorcom.com Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY KEEPS

More information

Central and Eastern Europe Statistics 2005

Central and Eastern Europe Statistics 2005 Central and Eastern Europe Statistics 2005 An EVCA Special Paper November 2006 Edited by the EVCA Central and Eastern Europe Task Force About EVCA The European Private Equity and Venture Capital Association

More information

GLOBAL PRIVATE EQUITY Report Charts

GLOBAL PRIVATE EQUITY Report Charts GLOBAL PRIVATE EQUITY 2003 Report Charts THE WORLD VIEW Investment & Fund Raising Trends THE WORLD VIEW 2002 Main Headlines At least $102 billion of private equity and venture capital was invested globally

More information

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011) Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011) Background We analyzed the terms of venture financings for 117 companies headquartered in Silicon Valley that reported raising

More information

CLEAN ENERGY PIPELINE 2Q15: GLOBAL CLEAN ENERGY REVIEW ANALYTICS AND GRAPHS

CLEAN ENERGY PIPELINE 2Q15: GLOBAL CLEAN ENERGY REVIEW ANALYTICS AND GRAPHS CLEAN ENERGY PIPELINE : GLOBAL CLEAN ENERGY REVIEW ANALYTICS AND GRAPHS CONTACT CLEAN ENERGY PIPELINE For any questions regarding the information contained herewith or to request additional data / information,

More information

Canada Venture Capital Market Overview First Nine Months of 2015

Canada Venture Capital Market Overview First Nine Months of 2015 Canada Venture Capital Market Overview First Nine Months of 2015 Page 2 Deals by Quarter # Deals $ Millions Invested 160 140 120 100 80 60 40 84 80 101 97 111 92 109 119 135 132 143 700 600 500 400 300

More information

Silicon Valley Venture Capital Survey Fourth Quarter 2018

Silicon Valley Venture Capital Survey Fourth Quarter 2018 fenwick & west Silicon Valley Venture Capital Survey Fourth Quarter 2018 First Look Silicon Valley Venture Capital Survey Fourth Quarter 2018 fenwick & west First Look Cynthia Clarfield Hess, Mark Leahy

More information

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010 CONTACTS Channa Brooks Tenor Communications for NVCA 1.302.368.2345 channa@tenorcom.com Daniel Billings Thomson Reuters 1.646 223 5985 daniel.billings@thomsonreuters.com Exit Activity Shows Improved Signs

More information

Trends in Healthcare Investments and Exits 2018

Trends in Healthcare Investments and Exits 2018 Trends in Healthcare Investments and Exits 208 208 Massachusetts Life Science Innovation Day Clark Hayes Managing Director Life Science/Healthcare Northeast Head of Business Development SVB Corporate Overview

More information

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS European Private Equity Buyout Review First Quarter 2017 Fabrizio Bensch REUTERS Table of Contents Europe s PE Buyout Market in Q1 2017 3 Invested and # Companies Financed 4 Top PE Buyout Deals 6 Investment

More information

European inv n estme m nt n s

European inv n estme m nt n s European investments October 2016 1. Investment data with a focus on Europe and France 2 Funding stages in a nutshell INCEPTION PROTOTYPE GROWTH EXPANSION MATURITY LARGE VENTURE PUBLIC PRIVATE EQUITY MBO/LBO

More information

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Overview of Venture Equity

Overview of Venture Equity Overview of Venture Equity SVB Analytics Report 2017 Written by SVB Analytics: Steve Liu Managing Director sliu@svb.com Sean Lawson Senior Manager slawson2@svb.com Steven Pipp Senior Associate spipp@svb.com

More information

German & Berlin Tech: performance on the international stage. 14 November 2018 in partnership with

German & Berlin Tech: performance on the international stage. 14 November 2018 in partnership with German & Berlin Tech: performance on the international stage 14 November 2018 in partnership with Data trusted by leading publications 2 How are German & Berlin Tech performing on the international stage?

More information

EY survey of investment in innovative companies in France. First half of 2018

EY survey of investment in innovative companies in France. First half of 2018 EY survey of investment in innovative companies in France First half of 2018 Editorial Franck Sebag EY Partner In charge of the Fast Growing Companies department & IPO Western Europe & Maghreb World champions?

More information

2011 Angel Group Year in Review

2011 Angel Group Year in Review 2011 Angel Group Year in Review What is the Halo Report? Angel Group Investment Trends: The Angel Resource Institute, Silicon Valley Bank and CB Insights set out to raise awareness of early stage investment

More information

UNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016

UNITED INTERNET. Business Applications Strategic Partnership with Warburg Pincus. November 8, Investor Presentation November 8, 2016 UNITED INTERNET Business Applications Strategic Partnership with Warburg Pincus November 8, 2016 1 Investor Presentation November 8, 2016 1&1 INTERNET SE WITHIN UNITED INTERNET GROUP WP XII Venture Holdings

More information

Venture Capital Search Highlights

Venture Capital Search Highlights Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more

More information

European Trends in Healthcare Investments and Exits 2018

European Trends in Healthcare Investments and Exits 2018 European Trends in Healthcare Investments and Exits 2018 ANNUAL REPORT 2018 Nooman Haque Managing Director Life Science & Healthcare Bobby Anderson Senior Associate Life Science & Healthcare Vojtech Trebicky

More information

Average M&A Deal Size at Highest Level Since 2004

Average M&A Deal Size at Highest Level Since 2004 CONTACTS Ben Veghte NVCA 1.703.778.9292 bveghte@nvca.org Lauren Herman Thomson Reuters 1.646.223.5985 lauren.herman@thomsonreuters.com VENTURE-BACKED IPO EXIT ACTIVITY MAINTAINS MOMENTUM WITH BEST QUARTER

More information

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT Contacts: Clare Chachere, PwC US, 512-867-8737, clare.chachere@us.pwc.com Jeffrey Davidson, Brainerd Communicators for PwC, 212-739-6733, davidson@braincomm.com Ben Veghte, NVCA, 703-778-9292, bveghte@nvca.org

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

Venture capital - An introduction into the nature of venture capital

Venture capital - An introduction into the nature of venture capital 08-4-2000 Venture capital - An introduction into the nature of venture capital Boris Brosowski South Africa Table of contents: 1. INTRODUCTION... 3 2. THE NATURE OF VENTURE CAPITAL... 3 2.1. WHAT IS VENTURE

More information

Software was the Most Active and Highest Value Segment in 2015 with 1,288 Transactions Totaling $61.5 Billion in Reported Deal Value.

Software was the Most Active and Highest Value Segment in 2015 with 1,288 Transactions Totaling $61.5 Billion in Reported Deal Value. 2015 Summary of M&A and Investment Activity in the : 1,903 Totaling a $99.6 Billion Software was the Most Active and Highest Value Segment in 2015 with 1,288 Totaling $61.5 Billion in Deal Value December

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Forum Science & Business FCRi - EY Foundation

Forum Science & Business FCRi - EY Foundation Forum Science & Business FCRi - EY Foundation How European Policy could help the Entrepreneurial and Venture Capital Ecosystems 16 th April 2015 Anne Glover Chief Executive, Amadeus Capital & EVCA Chairman

More information

OECD/ADBI 7th Round Table on Capital Market Reform in Asia October 2005 ADB Institute, Tokyo, Japan

OECD/ADBI 7th Round Table on Capital Market Reform in Asia October 2005 ADB Institute, Tokyo, Japan OECD/ADBI 7th Round Table on Capital Market Reform in Asia 27-28 October 2005 ADB Institute, Tokyo, Japan SESSION 4: DEVELOPMENTS IN VENTURE CAPITAL AND PRIVATE EQUITY SINCE THE END OF TECH BUBBLE Mr.

More information

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

CANADIAN PRIVATE EQUITY BUYOUT REVIEW CANADIAN PRIVATE EQUITY BUYOUT REVIEW First Three Quarters 2015 REUTERS / Todd Korol Table of Contents Canada s PE Buyout Market in First 3Q 2015 3 $ Invested and # Companies Financed 5 Top Buyout Deals

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

Net Lease Investment Outlook

Net Lease Investment Outlook United States H1 2018 JLL Research Report Net Lease Investment Outlook First half of 2018 outperforms but overall selectivity prevails 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Net lease

More information

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter. Moving Ahead Third-quarter Technology venture capital investment increased 33 percent yearover-year but decreased 6 percent quarter-over-quarter October 2 PwC US venture capital funding for the Technology

More information

Understanding Venture Capital

Understanding Venture Capital Understanding Venture capitalists believe innovation is the foundation of Michigan s growing economy. As a result, over the last 15 years, the venture capital industry has become a significant driver in

More information

2014 Global venture capital confidence survey results

2014 Global venture capital confidence survey results 2014 Global venture capital confidence survey results How confident are investors? August 13, 2014 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing

More information

Angel Group Update: Q2 2013

Angel Group Update: Q2 2013 Angel Group Update: Q2 2013 Table of Contents Q2 2013 Highlights p. 4 National Trends p. 6 Most Active Angels p.13 Regional Trends p. 16 Sector Trends p. 21 About the Halo Report p. 24 2 Q2 2013 Highlights

More information

Silicon Valley Venture Capital Survey Third Quarter 2017

Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west Silicon Valley Venture Capital Survey Third Quarter 2017 First Look Silicon Valley Venture Capital Survey Third Quarter 2017 fenwick & west First Look Cynthia Clarfield Hess, Mark Leahy

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management M&A Update 1H 2017 Accounts Receivable Management Healthcare IT Revenue Cycle Management Proven. Focused. Trusted. 301-576-4000 www.greenberg-advisors.com Proven. Focused. Trusted Revenue Cycle Management

More information

presents THE ANGEL CONNECTION

presents THE ANGEL CONNECTION presents THE ANGEL CONNECTION THANK YOU SPONSORS Premier Partner THANK YOU SPONSORS Premier Partner THANK YOU SPONSORS Premier Partner THANK YOU SPONSORS Site Partner THANK YOU SPONSORS Association Partners

More information

Florida Venture Factbook

Florida Venture Factbook S E AT T L E SAN FRANCISCO NEW YORK LONDON Florida Venture Factbook 2019 pitchbook.com US + 1 206.623.1986 UK + 44 (0)207.190.9809 demo@pitchbook.com PG 1 Dear Attendee, On behalf of the Florida Venture

More information

5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% 16.00% 13.00% 10.00% 7.00% 4.

5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% 16.00% 13.00% 10.00% 7.00% 4. MARKETBEAT The DNA of Real Estate EUROPE A Cushman & Wakefield Research Publication Q4 2014 ICE RENTAL (YEAR-ON-YEAR) Q4 2012 Q4 2013 Q4 2014 All Countries 0.2% 0.7% 0.2% Western Europe -0.5% 0.7% 1.8%

More information

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 ($ in trillions) KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR +21% CAGR Alternative AUM +12% CAGR $190 (1) ($ in billions)

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

A report on investment gender diversity in the Nordics

A report on investment gender diversity in the Nordics A report on investment gender diversity in the Nordics The Nordic Web The Nordic Web is the number one resource for data-driven analysis on the Nordic tech and startup scene and is read and relied on by

More information

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

CANADIAN PRIVATE EQUITY BUYOUT REVIEW CANADIAN PRIVATE EQUITY BUYOUT REVIEW First Half 2016 REUTERS Table of Contents Canada s PE Buyout Market in Q2 2016 3 $ Invested and # Companies Financed 5 Top Buyout Deals 9 Canada by Market Segment

More information

Mary Macdonald November 2005

Mary Macdonald November 2005 Overview of Venture Capital in Canada Investment Saskatchewan Leaders Forum Mary Macdonald November 2005 Private Equity Data Comprehensive information available on venture capital activity = detailed trend

More information

Private Equity-Backed Buyout Deals and Exits Down in Q Market Volatility and Tightened Credit Markets Lead to an Absence of Large-Cap Deals

Private Equity-Backed Buyout Deals and Exits Down in Q Market Volatility and Tightened Credit Markets Lead to an Absence of Large-Cap Deals Press Release 3 rd October 211 Equity-Backed Buyout Deals and Exits Down in 211 Market Volatility and Tightened Credit Markets Lead to an Absence of Large-Cap Deals Preqin s quarterly deals data shows

More information

Q Q Cleantech Investment Monitor VOL. 7 / ISSUE 1.

Q Q Cleantech Investment Monitor VOL. 7 / ISSUE 1. Q1 2008 Q1 2008 VOL. 7 / ISSUE 1 Cleantech Investment Monitor we put the squeaky in your CLEAN If you are a cleantech leader looking to engage advocates worldwide with strategic PR, please contact: William

More information

Private Equity Market Update. February 2013

Private Equity Market Update. February 2013 Private Equity Market Update February 213 U.S. Private Equity Deal Activity Deal activity in the first three quarters of 212 was lower than the corresponding quarters in 211 due to a number of factors.

More information

Mara H. Rogers, Partner Norton Rose Fulbright

Mara H. Rogers, Partner Norton Rose Fulbright Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers

More information

THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET

THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET 1 A LONGER ROAD TO THE PUBLIC MARKET... For decades, there has been a well-worn path for innovative and fast-growing companies funded by venture capitalists

More information

IVC-MEITAR HIGH-TECH EXITS 2015 REPORT 2015 exits peak at $9.02B 3 rd strongest year in 10 years

IVC-MEITAR HIGH-TECH EXITS 2015 REPORT 2015 exits peak at $9.02B 3 rd strongest year in 10 years IVC-MEITAR HIGH-TECH EXITS 215 REPORT 215 exits peak at $9.2B 3 rd strongest year in 1 years Israeli High-Tech Exit Highlights $9.2B exit proceeds in 215 up 16% from 214 215 average exit rises to $87 million

More information

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by: 4Q 2012 Private Equity Company Inventory Report Sponsored by: www.newstarfin.com Introduction In the last few quarters, an overwhelming number of the inquiries coming in to the Research Team have centered

More information

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value jd1 3Q17 Summary of M&A and Investment Activity in the : 814 Totaling a $49.4 Billion Software was the Most Active and Highest Value Segment in 3Q17 with 606 Totaling $29.4 Billion in Deal Value During

More information

Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile

Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile Q3 2011 Insight Analysis Experience the power of being understood. SM Powered by PitchBook McGladrey Announces the Q3 2011 Private

More information

EVCA Strategic Priorities

EVCA Strategic Priorities EVCA Strategic Priorities EVCA Strategic Priorities The following document identifies the strategic priorities for the European Private Equity and Venture Capital Association (EVCA) over the next three

More information

1H16 Summary of M&A and Investment Activity in the. Marketing, Media, and Technology Industries. 1,509 Transactions Totaling a Reported $74.

1H16 Summary of M&A and Investment Activity in the. Marketing, Media, and Technology Industries. 1,509 Transactions Totaling a Reported $74. 1H16 Summary of M&A and Investment Activity in the : 1,509 Totaling a $74.4 Billion Digital Media/Commerce was the Most Active Segment with 614, Followed by Marketing Technology with 474 ; Digital Media/Commerce

More information

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r Company Profile November 2011 Migdal Underwriting & Business initiatives Ltd. Company Profile Migdal Underwriting & Business initiatives Ltd., is the investment banking arm of the Migdal Group, one of

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA Press release Baar, 28 January 2008 Attractive portfolio of investments in biotech and medical technology to be opened to the public HBM BioVentures announces further information of its planned IPO on

More information

24 May, Pan-European Private Equity and Venture Capital Activity

24 May, Pan-European Private Equity and Venture Capital Activity 24 May, 211 21 Pan-European Private Equity and Venture Capital Activity 1 About the European Private Equity & Venture Capital Association EVCA is the voice of European private equity and venture capital.

More information

2017 Venture Capital Update. Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017

2017 Venture Capital Update. Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017 2017 Venture Capital Update Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017 Agenda U.S. VC trends through year-end 2016 VC trends in Texas & Dallas Policy priorities

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

Drivers of Innovation in the US High Tech Model

Drivers of Innovation in the US High Tech Model Entrepreneurship and Venture Capital Jerome S. Engel Adjunct Professor, Haas School of Business Executive Director, Lester Center For Entrepreneurship and Innovation University of California at Berkeley

More information